Fe3 Medical's Series B - II Round

Fe3 Medical raised a round of funding on August 08, 2016. Investors include Texas Emerging Technology Fund.

Fe3 Medical has developed a novel transdermal patch for the treatment of iron-deficiency anemia, one of the world's most prevalent micro-nutrient deficiencies. Roughly a third of the US population suf…

Articles about Fe3 Medical's Series B - II Round: